Table 3.
Multidrug-resistance patterns of E. faecium and E. faecalis from intestinal tract of hospitalized patients in Jimma, Ethiopia
| No. of antibiotics | Resistance patterns | Number of E. faecium with pattern | Number of E. faecalis with pattern | Total number of MDR (%) |
|---|---|---|---|---|
| R3 | AMP, HLR-GN, TE | 30 | 5 | 102 (89.5) |
| HLR-GN, TE, FD | 16 | 5 | ||
| TE, FD, CIP | 17 | 13 | ||
| FD, ERY, CL | 5 | 11 | ||
| R4 | AMP, HLR-GN, TE, FD | 16 | 3 | 55 (48.2) |
| HLR-GN, TE, FD, CIP | 16 | 4 | ||
| TE, FD, ERY, CL | 5 | 11 | ||
| R5 | AMP, HLR-GN, TE, FD, CIP | 16 | 2 | 29 (25.4) |
| HLR-GN, TE, FD, ERY, CL | 5 | 4 | ||
| TE, FD, ERY, CL, VA | 2 | 0 | ||
| R6 | HLR-GN, TE, FD, ERY, CL, VA | 2 (100) | 0 | 2 (1.75) |
| R7 | AMP, HLR-GN, TE, FD, ERY, CL, VA | 2 (100) | 0 | 2 (1.75) |
MDR non-susceptible to ≥1 agent in ≥3 antimicrobial categories, R3 resistance to three antibiotics, R4 resistance to four antibiotics, R5 resistance to five antibiotics, R6 resistance to six antibiotics, R7 resistance to seven antibiotics, AMP ampicilin, HLR-GN high level resistance to gentamycin, TE tetracycline, FD Nitrofrantoin, CIP ciprofloxacin, CL chloramphenicol, ERY erythromycin, VA vancomycin.